BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15657353)

  • 1. Selective inhibitors of MEK1/ERK44/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells.
    Sun Y; Sinicrope FA
    Mol Cancer Ther; 2005 Jan; 4(1):51-9. PubMed ID: 15657353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.
    Rice PL; Goldberg RJ; Ray EC; Driggers LJ; Ahnen DJ
    Cancer Res; 2001 Feb; 61(4):1541-7. PubMed ID: 11245463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.
    Rice PL; Washington M; Schleman S; Beard KS; Driggers LJ; Ahnen DJ
    Cancer Res; 2003 Feb; 63(3):616-20. PubMed ID: 12566304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p38MAPK inhibitor SB203580 sensitizes human SNU-C4 colon cancer cells to exisulind-induced apoptosis.
    Lim SJ; Lee YJ; Lee E
    Oncol Rep; 2006 Nov; 16(5):1131-5. PubMed ID: 17016604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.
    Cusimano A; Foderà D; D'Alessandro N; Lampiasi N; Azzolina A; Montalto G; Cervello M
    Cancer Biol Ther; 2007 Sep; 6(9):1461-8. PubMed ID: 18424914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment with arsenic trioxide and sulindac enhances apoptotic cell death in lung cancer cells via activation of oxidative stress and mitogen-activated protein kinases.
    Park JH; Kim EJ; Jang HY; Shim H; Lee KK; Jo HJ; Kim HJ; Yang SH; Jeong ET; Kim HR
    Oncol Rep; 2008 Aug; 20(2):379-84. PubMed ID: 18636201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged activation of mitogen-activated protein kinases during NSAID-induced apoptosis in HT-29 colon cancer cells.
    Kim TI; Jin SH; Kim WH; Kang EH; Choi KY; Kim HJ; Shin SK; Kang JK
    Int J Colorectal Dis; 2001 Jun; 16(3):167-73. PubMed ID: 11459290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells.
    Elder DJ; Halton DE; Playle LC; Paraskeva C
    Int J Cancer; 2002 May; 99(3):323-7. PubMed ID: 11992399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulindac sulfide-induced apoptosis in sinonasal cancer cells.
    Kim CH; Song KS; Kim KS; Kim JY; Lee BJ; Lee JG; Yoon JH
    Acta Otolaryngol; 2005 Feb; 125(2):201-6. PubMed ID: 15880954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of early growth response gene 1 (EGR-1) via ERK1/2 signals attenuates sulindac sulfide-mediated cytotoxicity in the human intestinal epithelial cells.
    Moon Y; Yang H; Kim YB
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):155-63. PubMed ID: 17599376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway.
    Yu C; Wang S; Dent P; Grant S
    Mol Pharmacol; 2001 Jul; 60(1):143-54. PubMed ID: 11408609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways.
    Rice PL; Peters SL; Beard KS; Ahnen DJ
    Mol Cancer Ther; 2006 Mar; 5(3):746-54. PubMed ID: 16546990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2.
    Sinicrope FA; Penington RC
    Mol Cancer Ther; 2005 Oct; 4(10):1475-83. PubMed ID: 16227396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cyclooxygenase inhibitor sulindac sulfide inhibits EP4 expression and suppresses the growth of glioblastoma cells.
    Kambe A; Yoshioka H; Kamitani H; Watanabe T; Baek SJ; Eling TE
    Cancer Prev Res (Phila); 2009 Dec; 2(12):1088-99. PubMed ID: 19934343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel combination of cyclooxygenase-2 and MEK inhibitors in human hepatocellular carcinoma provides a synergistic increase in apoptosis.
    Schmidt CM; Wang Y; Wiesenauer C
    J Gastrointest Surg; 2003 Dec; 7(8):1024-33. PubMed ID: 14675712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of extracellular-signal regulated kinases 1/2 is required for apoptosis of human colon cancer cells in vitro by sulindac metabolites.
    Rice PL; Beard KS; Driggers LJ; Ahnen DJ
    Cancer Res; 2004 Nov; 64(22):8148-51. PubMed ID: 15548677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of MAP kinases with COX-2 induction differs between MKN45 and HT29 cells.
    Tominaga K; Higuchi K; Sasaki E; Suto R; Watanabe T; Fujiwara Y; Oshitani N; Matsumoto T; Kim S; Iwao H; Arakawa T
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():143-50. PubMed ID: 15298620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ERK and activation of p38 are involved in diallyl disulfide induced apoptosis of leukemia HL-60 cells.
    Tan H; Ling H; He J; Yi L; Zhou J; Lin M; Su Q
    Arch Pharm Res; 2008 Jun; 31(6):786-93. PubMed ID: 18563362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.